Purchases and Sales Made in Q2 2023 in Rain Therapeutics Inc. (RAIN)
This table provides information about the institutional ownership of Rain Therapeutics Inc. (RAIN) during Q2 2023. The information is specifically focused on institutions that hold shares of Rain Therapeutics Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Point72 Middle East Fze
Stamford, CT |
BUY
|
- |
132New |
$144 - $1.31K
|
132
$0
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-8.27K- 54.53% |
$9.02K - $82.1K
|
6.9K
$0
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-22.1K- 86.86% |
$24.1K - $219K
|
3.34K
$0
|
|
Aug 09, 2023
Q2 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-33K- 70.47% |
$36K - $328K
|
13.8K
$0
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-35.6K- 87.46% |
$38.8K - $354K
|
5.11K
$0
|
|
Aug 14, 2023
Q2 2023
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-226K- 10.0% |
$246K - $2.25M
|
2.03M
$0
|
|
Aug 14, 2023
Q2 2023
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-995K- 46.34% |
$1.08M - $9.88M
|
1.15M
$0
|